Healthy adults
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Who can understand the contents of the study and can consent to the participation to the study after receiving the explanation. 2) Persons older than 20 years and younger than 74 years at the date of consent whose blood test values at the time of screening are in range shown in the point. LDL (mg/dL)60-139, HDL(mg/dL):40-119, triglyceride(mg/dL):30-199, WBC(times1,000/microliter):3.2-8.9, RBC(times10,000/microliter):male 400-599,female:360-549, AST(GOT):(U/L)0-35, ALT(GPT) (U/L):0-40, creatinine(mg/dL):male:under 1.09 female:under 0.79, HbA1c(parcent):under 5.9
Exclusion criteria
Exclusion criteria: 1) Whose blood markers levels examined at the time of screening are not normal. 2) Who is using drug or food that principle-investigator or sub-investigator judged to affect the result of the study. 3) Who are participating or are planning to participate to other interventional study. 4) Who have donated blood more than 400mL within the last three months or more than 200mL within the last one month before the date of consent. 5) Who is judged to be unsuitable for this study by principle-investigator or sub-investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood test (oxidized LDL, LDL, HDL, triglyceride) | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood test (WBC, RBC, HbA1c, AST (GOT), ALT (GPT), creatinine, CRP, IgA) Physical examination (body weight, body fat, arteriosclerosis examination, blood flow measurement) Questionnaire (neck stiffness, feeling of coldness, feeling of hotness, bowel movement, sleep, common cold) | — |
Countries
Japan
Contacts
Linking Setouchi Innate immune Network Secretariat